David J. Mauro, Chief Medical Officer at Prelude Therapeutics Inc (PRLD), sold 50,000 shares at $35.68 ($1.8M) on 2021-04-27, disclosed to the SEC on 2021-04-29.
Open-market sale of $1.8M PRLD by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.66 | 7,688 | $266K | 15.1% |
| 2 | $34.66 | 7,688 | $266K | 15.1% |
| 3 | $35.68 | 15,601 | $557K | 31.5% |
| 4 | $35.68 | 15,601 | $557K | 31.5% |
| 5 | $36.11 | 1,711 | $62K | 3.5% |
| 6 | $36.11 | 1,711 |
| $62K |
| 3.5% |
| Total | $35.40 avg | 50,000 | $1.8M | 100% |
| Filing → |
| PRLD | SELL | 2021-08-09 | $930K | — | Filing → |
| PRLD | SELL | 2021-07-08 | $816K | — | Filing → |
| PRLD | SELL | 2021-06-09 | $902K | — | Filing → |